The Center for Global Health Policy’s “Science Speaks” blog discusses findings of a “four-year South Africa study of co-infected patients [that] showed starting treatment for HIV during the course of anti-tuberculosis treatment, rather than waiting until TB treatment was completed, improved survival rates among those whose tuberculosis was responsive to first-line treatment.” Now, “[u]nder the funding model of the Global Fund to Fight AIDS, Tuberculosis and Malaria this year, countries with high TB-HIV co-infection rates will be required to submit joint TB-HIV concept notes which present integrated and joint programming for the two diseases…” (Aziz, 2/19).